Chapter 23 Intestinal barrier function

Biology of Growing Animals

Volumn 1, Issue C, 2002, Pages 657-693

  Bjarnason, I ^a,b   Cederborg, A ^a,b   akvist A ^a,b   Smale, S ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34047271198     PISSN: 18771823     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1823(09)70139-0     Document Type: Article

References (269)

1. Alam A.N., Sarker S.A., Wahed M.A., Khatun M., and Rahaman M.M. Enteric protein loss and intestinal permeability changes in children during acute shigellosis and after recovery: effect of zinc supplementation. Gut 35 (1994) 1707-1711
2. Albert L.J., and Inman R.D. Molecular mimicry and autoimmunity. N. Eng. J. Med. 341 (1999) 2068-2074
3. Allison M.C., Howatson A.G., Torrance C.J., Lee F.D., and Russell R.I. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N. Engl. J. Med. 327 (1992) 749-754
4. Andre C. Diagnostic objectif et test L'efficacite therapeutique par mesure de la permeabilite intestine. Presse Med. 15 (1986) 105-108
5. Andre C., Andre F., Colin L., and Cavagna S. Measurement of intestinal permeability to mannitol and lactulose as a means of diagnosing food allergy and evaluating therapeutic effectiveness of disodium chromoglycate. Ann. Allergy 59 (1987) 127-130
6. Andre C., Collin L., Descos L., and Daniere S. Non-invasive evaluation of intestinal permeability in food allergy, coeliac disease and inflammatory bowel disease. Gut 25 (1984) A1189-A1190
7. Andre F., Andre C., and Emery Y. Assessement of the lactulose-mannitol test in Crohn's disease. Gut 29 (1988) 511-515
8. Arnott I.D., Kingstone K., and Ghosh S. Abnormal intestinal permeability predicts relapse in inactive Crohn's disease. Scand. J. Gastroenterol. 35 (2000) 1163-1169
9. Arvola T., Isolauri E., Rantala I., Kaila M., Majamaa H., Virtanen E., and Arviommi H. Increased in vitro intestinal permeability in suckling rats to cow milk during lactation. J. Pediat. Gastroenterol. Nutr. 16 (1993) 294-300
10. Atherton D.J. Allergy and atopic eczema II. Clin. Experim. Dermatol. 6 (1981) 317-325
11. Atherton D.J., Sewell M., Soothill J.F., Wells R.S., and Chivers C.D. A double blind, controlled, crossover trial of antigen avoidance diet in atopic eczema. Lancet i (1978) 401-403
12. Baldas V., Tommasini A., Trevisiol C., Berti I., Fasano A., Sblattero D., Bradbury A., Marzari R., Barillari G., Ventura A., and Not T. Development of a novel rapid non-invasive screening test for coeliac disease. Gut 47 (2000) 628-631
13. Bao Y., Silva T.M., Guerrant R.L., Lima A.A., and Fox J.W. Direct analysis of mannitol, lactulose and glucose in urine samples by high-performance anion-exchange chromatography with pulsed amperometric detection. Clinical evaluation of intestinal permeability in human immunodeficiency virus infection. J. Chromatogr. B. Biomed. Allp. 685 (1996) 105-112
14. Barau E., and Dupont C. Modifications of intestinal permeability during food provocation procedures in pediatric irritable bowel syndrome. J. Pediat. Gastroenterol. Nutr. 11 (1990) 72-77
15. Barba A., Schena D., Andreaus M.C., Faccini G., Pasini F., Brocco G., Cavallini G., Scuro L.A., and Chieregato G.C. Intestinal permeability in patients with atopic eczema. Brit. J. Dermatol. 120 (1989) 71-75
16. Barboza Jr. M.S., Silva T.M., Guerrant R.L., and Lima A.A. Measurement of intestinal permeability using mannitol and lactulose in children with diarrheal diseases. Braz. J. Med. Biol. Res. 32 (1999) 1499-1504
17. Behrens R.H., Lunn P.G., Northrop C.A., Hanlon P.W., and Neale G. Factors affecting the integrity of the intestinal mucosa of Gambian children. Amer. J. Clin. Nutr. 45 (1987) 1433-1441
18. Bjarnason I., Batt R., Catt S., Macpherson A., Maxton D., and Menzies I.S. Evaluation of differential disaccharide excretion in urine for non-invasive assessment of intestinal disaccharidase activity caused by a-glucosidase inhibition, primary hypolactasia and coeliac disease. Gut 39 (1996) 374-381
19. Bjarnason I., Fehilly B., Smethurst P., Menzies I.S., and Levi A.J. The importance of local versus systemic effects of non-steroidal anti-inflammatory drugs to increase intestinal permeability in man. Gut. 32 (1991) 275-277
20. Bjamason I., Goolamali S.K., Levi A.J., and Peters T.J. Intestinal permeability in patients with atopic eczema. Brit. J. Dermatol. 112 (1985) 291-297
21. Bjamason I., Hayllar J., Macpherson A.J., and Russell A.S. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine. Gastroenterology 104 (1993) 1832-1847
22. Bjamason I., Hayllar J., Smethurst P., Price A.B., Menzies I.S., and Gumpel M.J. Metronidazole reduces inflammation and blood loss in NSAID enteropathy. Gut 33 (1992) 1204-1208
23. Bjarnason I., Macpherson A., Somasundaram S., and Teahon K. Nonsteroidal antiinflammatory drugs and inflammatory bowel disease. Can. J. Gastroenterol. 7 (1993) 160-169
24. Bjarnason I., Macpherson A.J.M., and Hollander D. Intestinal permeability: An overview. Gastroenterology 108 (1995) 1566-1581
25. Bjamason, I., Macpherson, A.J.S., Somasundaram, S., Teahon, K., 1993b. Non-steroidal anti-inflammatory drugs and Crohn's disease. In: Scholmeric, J., Kruis, W., Goebbell, H., Hohenberger, W., Gross, V. (Eds.), Inflammatory bowel diseases: Pathophysiology as basis of treatment. Falk Symposium No 67. Kluwer Academic Publishers, Lancaster 208-222.
26. Bjamason I., Marsh M.N., Price A., Levi A.J., and Peters T.J. Intestinal permeability in patients with coeliac disease and dermatitis herpetiformis. Gut 26 (1986) 1214-1219
27. Bjarnason I., Maxton D., Reynolds A.P., Catt S., Peters T.J., and Menzies I.S. A comparison of 4 markers of intestinal permeability in control subjects and patients with coeliac disease. Scand. J. Gastroenterol. 26 (1994) 630-639
28. Bjarnason I., O'Morain C., Levi A.J., and Peters T.J. The absorption of 51Cr EDTA in inflammatory bowel disease. Gastroenterology 85 (1983) 318-322
29. Bjarnason I., Peters T.J., and Veall N. A persistent defect of intestinal permeability in coeliac disease as demonstrated by a 51Cr-labelled EDTA absorption test. Lancet i (1983) 323-325
30. Bjarnason I., Smethurst P., Macpherson A., Walker F., McElnay J.C., Passmore A.P., and Menzies I.S. Glucose and citrate reduce the permeability changes caused by indomethacin in humans. Gastroenterology 102 (1992) 1546-1550
31. Bjarnason I., Smethurst P., Menzies I.S., and Peters T.J. The effect of polyacrylic acid polymers (carbopol) on small intestinal function and permeability changes caused by indomethacin. Scand. J. Gastroenterol. 26 (1991) 685-688
32. Bjarnason I., Ward K., and Peters T.J. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet i (1984) 179-182
33. Bjarnason I., Williams P., Smethurst P., Peters T.J., and Levi A.J. The effect of NSAIDs and prostaglandins on the permeability of the human small intestine. Gut 27 (1986) 1292-1297
34. Bjarnason I., Williams P., So A., Zanelli G., Levi A.J., Gumpel M.J., Peters T.J., and Ansell B. Intestinal permeability and inflammation in rheumatoid arthritis; effects of non-steroidal anti-inflammatory drugs. Lancet ii (1984) 1171-1174
35. Bjarnason I., Zanelli G., Smethurst P., Burke M., Gumpel M.J., Price A.B., and Levi A.J. Clinico-pathological features of nonsteroidal antiinflammatory drug induced small intestinal structures. Gastroenterology 94 (1988) 1070-1074
36. Bjarnason I., Zanelli G., Smith T., Prouse P., Williams P., DeLacey G., Gumpel M.J., and Levi A.J. Nonsteroidal antiinflammatory drug induced intestinal inflammation in humans. Gastroenterology 93 (1987) 480-489
37. Borch K., Sjostedt C., Hammestad U., Soderholm J.D., Franzen L., and Mardh S. Asymptomatic Helicobacter pylori gastritis is associated with increased sucrose permeability. Dig. Dis. Sci. 43 (1998) 749-753
38. Brace R.A. Physiology of amniotic fluid regulation. Clin. Obstet. Gyn. 40 (1997) 280-289
39. Brooks A.D., Hochwald S.N., Heslin M.J., Harrison L.E., Burt M., and Brennan M.F. Intestinal permeability after early postoperative enteral nutrition in patients with upper gastrointestinal malignaney. J. Parent. Enter. Nutr. 23 (1999) 75-79
40. Buchman A.L., Moukarzel A.A., Bhuta S., Belle M., Ament M.E., Eckhert C.D., Hollander D., Gornbein J.V., Kopple J.D., and Ijayaroghavan S.R. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. J. Parent. Enter. Nutr. 19 (1995) 453-460
41. Budillon G., Parrilli G., Pacella M., Cuomo R., and Menzies I.S. Investigation of intestine and liver function in cirrhosis using combined sugar oral loads. J. Hepatol. 1 (1985) 513-524
42. Campillo B., Pernet P., Bories P.N., Richardet J.P., Devanlay M., and Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur. J. Gastroenterol. Hepatol. 11 (1999) 755-759
43. Carefoli E. Intra cellular calcium homeostasis. Ann. Rev. Biochem. 56 (1987) 395-433
44. Carratu R., Secondulfo M., de Magistris L., Daniele B., Pignata S., D'Agostino L., Frezza P., Elmo M., Silvestro G., and Sasso F.S. Assessment of small intestinal damage in patients treated with pelvic radiotherapy. Oncol. Rep. 5 (1998) 635-639
45. Carratu R., Secondulfo M., de Magistris L., Iafusco D., Urio A., Carbone M.G., Pontoni G., Carteni M., and Prisco F. Altered intestinal permeability to mannitol in diabetes mellitus type I. J. Pediat. Gastroenterol. Nutr. 28 (1999) 264-269
46. Casellas F., Aguade S., Soriano B., Accarino A., Molero J., and Guarner L. Intestinal permeability to 99mTc diethylene-tetraaminopentaacetic acid in inflammatory bowel disease. Amer. J. Gastroenterol. 81 (1986) 767-770
47. Catassi C., Bonucci A., Coppa G.V., Carlucci A., and Giorgi P.L. Intestinal permeability changes during the first month: effect of natural versus artificial feeding. J. Pediat. Gastroenterol. Nutr. 21 (1995) 383-386
48. Catassi C., Rossini M., Ratsch I.-M., Bearzi I., Santinelli A., Castagnani R., Pisani E., Coppa G.V., and Giorgi P.L. Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. Gut 34 (1993) 1515-1519
49. Chadwick V.S., Phillips S.F., and Hofman A.F. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). I. Chemical analysis and biological properties of PEG 400. Gastroenterology 73 (1977) 241-246
50. Chadwick V.S., Phillips S.F., and Hofman A.F. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to study of normal and abnormal permeability states in man and animals. Gastroenterology 73 (1977) 247-251
51. Chantler C., Garnett E.S., Parsons V., and Veall N. Glomerular filtration rate measurement in man by the single injection method using 51CrEDTA. Clin. Sci. 37 (1969) 169-180
52. Choi V.M., Coates J.E., Chooi J., Thomson A.B., and Russell A.S. Small bowel permeability-a variable effect of NSAIDS. Clin. Invest. Med. 18 (1995) 357-361
53. Cobden I., Dickinson R.J., Rothwell J., and Axon A.T.R. Intestinal permeability assessed by excretion ratios of two molecules: Results in coeliac disease. Brit. Med. J. 2 (1978) 1060
54. Cobden I., Rothwell J., and Axon A.T.R. Intestinal permeability abd screening tests for coeliac disease. Gut 21 (1980) 512-518
55. Cobden I., Rothwell J., Axon A.T.R., Dixon M.F., Lintott D.J., and Rowell N.R. Small intestinal structure and passive permeability in systemic sclerosis. Gut 21 (1980) 293-298
56. Cooper B.T., Ukabam S.O., O'Brien I.A.D., Hara J.P.O., and Corrall R.J.M. Intestinal permeability in diabetic diarrhoea. Diabet. Medicine 4 (1987) 49-52
57. Cox M.A., Iqbal T.H., Lewis K.O., and Cooper B.T. Viewpoints in intestinal permeability. Gastroenterology 112 (1997) 669-670
58. Cox M.A., Lewis K.O., and Cooper B.Y. Sucrosaemia in untreated coeliac disease: a potential screening test. Dig. Dis. Sci. 43 (1998) 1096-1101
59. Cummins A.G., Penttila I.A., Labrooy J.T., Robb T.A., and Davidson G.P. Recovery of the small intestine in coeliac disease on a gluten-free diet: changes in intestinal permeability, small bowel morphology and T-cell activity. J. Gastroenterol. Hepatol. 6 (1991) 53-57
60. Cummins A.G., Thompson F.M., Butler R.N., Cassidy J.C., Gillis D., Lorenzetti M., Southcott E.K., and Wilson P.C. Improvement in intestinal permeability precedes morphometric recovery of the small intestine in coeliac disease. Clin. Sci. 100 (2001) 379-386
61. D'Eufemia P., Celli M., Finocchiaro R., Pacifico L., Viozzi L., Zaccagnini M., Cardi E., and Giardini O. Abnormal intestinal permeability in children with autism. Acta Paediat. 85 (1996) 1076-1079
62. D'Inca R., Di Leo V., Corrao G., Martines D., D'Odorico A., Mestriner C., Venturi C., Longo G., and Sturniolo G.C. Intestinal permeability test as a predictor of clinical course in Crohn's disease. Amer. J. Gastroenterol. 94 (1999) 2956-2960
63. Dahlqvist A. Specificity of human intestinal disaccharidases and implications for hereditary disaccharide intolerance. J. Clin. Invest. 41 (1962) 463-470
64. Davies K.N., King D., Billington D., and Barrett J.A. Intestinal permeability and orocaecal transit in elderly patients with Parkinson's disease. Postgrad. Med. J. 72 (1996) 164-167
65. Davin J.C., Forget P., and Mahieu P.R. Increased intestinal permeability to (51Cr)EDTA is correlated with IgA immune complex-plasma levels in children with IgA-associated nephropathies. Acta Pediatr. Scand. 77 (1988) 118-124
66. Dawson D.J., Lobley R.W., Burrows P.C., Notman J.A., Mahon M., and Holmes R. Changes in jejunal permeability and passive permeation of sugars in intestinal biopsies in coeliac disease and Crohn's disease. Clin. Sci. 74 (1988) 427-431
67. de Maar E.F., Kleibeuker J.H., Boersma-van Ek.W., The T.H., and van Son W.J. Increased intestinal permeability during cytomegalovirus infection in renal transplant recipients. Transpl. Int. 9 (1996) 576-580
68. Doig C.J., Sutherland L.R., Sandham J.D., Fick G.H., Verhoef M., and Meddings J.B. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill intensive care unit patients. Amer. J. Respir. Crit. Care Med. 158 (1998) 444-451
69. Dupont C., Barau E., Molkhou P., Raynaud F., Barbet J.P., and Dehennin L. Food-induced alteration in intestinal permeability in children with cow's milk-sensitive enteropathy and atopic dermatitis. J. Pediat. Gastroenterol. Nutr. 8 (1989) 459-465
70. Ersoz G., Aydin A., Erdem S., Yuksel D., Akarca U., and Kumanlioglu K. Intestinal permeability in liver cirrhosis. Eur. J. Gastroenterol. Hepatol. 11 (1999) 409-412
71. Fakuda Y., Bamba H., Okui M., Tamura K., Tamida N., Satomi M., Shimoyama T., and Hishigami T. Helicobacter pylori increases mucosal permeability of the stomach and small intestine. Digestion 63 1 (2001) 93-96
72. Falth-Magnusson K., Jansson G., Stenhammar L., Sundquist T., and Magnusson K.E. Intestinal permeability assessed with different-sized polyethylene glycols in children undergoing small-intestinal biopsy for suspected coeliac disease. Scand. J. Gastroenterol. 24 (1989) 40-46
73. Falth-Magnusson K., Kjellman N.I.M., Sundquist T., and Magnusson K.E. Gastrointestinal permeability in atopic and non-atopic mothers, assessed with different sized polyethylene glycols (PEG 400 and PEG 1000). Clin. Allergy 15 (1985) 565-570
74. Faries P.L., Simon R.J., Martella A.T., Lee M.J., and Machiedo G.W. Intestinal permeability correlates with severity of injury in trauma patients. J. Trauma. 44 (1998) 1031-1035
75. Fleming S.C., Kynaston J.A., Laker M.F., Pearson A.D., Kapembwa M.S., and Griffin G.E. Analysis of multiple sugar probes in urine and plasma by high-performance anion-exchange chromatography with pulsed electrochemical detection. Application in the assessment of intestinal permeability inhuman immunedeficiency virus infection. J. Chromatogr. 640 (1993) 293-297
76. Fordtran J.S., Clodi P.H., Soergel K.H., and Ingelfinger F.J. Sugar absorption tests, with special reference to 3-O-methyl-D-glucose and D-xylose. Ann. Int. Med. 57 (1962) 883-891
77. Forget P., Sodoyez-Goffaux F., and Zapitelli A. Permeability of the small intestine to 51CrEDTA in children with acute gastroenteritis or eczema. J. Pediat. Gastroenterol. Nutr. 4 (1985) 393-396
78. Fotherby K.J., Wraight K.J., and Neale G. 51CrEDTA/14C mannitol intestinal permeability test. Clinical use in screening for coeliac disease. Stand. J. Gastroenterol. 23 (1988) 171-177
79. Fradkin A., Yahav J., Diver-Haber A., Zemer D., and Jonas A. Colchicine enhances intestinal permeability in patients with familial Mediterranean fever. Eur. J. Clin Pharmacol. 51 (1996) 241-245
80. Goldman A.S., Goldblum R.M., and Schmalstieg F.C. Protective properties of human milk. Perinatal nutrition. Part Ill. In: Walker W.A., and Watkins J.S. (Eds). Nutrition in paediatrics. Basic Science and clinical applications. 2ed. (1990), BC Decker, Hamilton, Canada 449-457
81. Goldsborough, J., Francis, D.E.M., 1983. Dietary management. In: Coombes, R.A.A. (Ed.), Proceedings of the Second Fission's Food Allergy Workshop. The Medicine Publishing Foundation, Oxford, 89-95.
82. Goodgame R.W., Malaty H.M., el-Zimai T.Y., and Graham D.Y. Decrease in gastric mucosal permeability to sucrose following cure of Helicobacter pylori infection. Helicobacter 2 (1997) 44-47
83. Goto K., Chew F., Torun B., Peerson J.M., and Brown K.H. Epidemiology of altered intestinal permeability to lactulose and mannitol in Guatemalan infants. J. Pediat. Gastroenterol. Nutr. 28 (1999) 282-290
84. Gotteland M., Cruchet Munoz S., Araya Quezada M., Espinoza Madariaga J., and Brunser Tesarschu O. Intestinal permeability in the first year of life. The effect of diarrhea. An. Esp. Pediatr. 49 (1998) 125-128
85. Gotteland M., Cruchet S., and Verbeke J. Effect of Lactobacillus ingestion on the gastroduodenal mucosal barrier alteration induced by indomethacin. Aliment. Pharmacol. Ther. 15 (2001) 11-17
86. Gryboski J.D., Thayer W.R., Gabrielson I.W., and Spiro H.M. Disacchariduria in gastrointestinal disease. Gastroenterology 45 (1963) 633-637
87. Guarino A., Tarallo L., Guandalini S., Troncone R., Albano F., and Rubino A. Impaired intestinal function in symptomatic HIV infection. J. Pediat. Gastroenterol. Nutr. 12 (1991) 453-458
88. Hamilton I. Small intestinal permeability. In: Pounder R.E. (Ed). Recent advances in Gastroenterology-6. (1986), Churchill Livingstone, Edinburgh 73-91
89. Hamilton I., Cobden I., and Axon A.T.R. Intestinal permeability in coeliac disease: The response to gluten withdrawal and single dose gluten challange. Gut 23 (1982) 202-210
90. Hamilton I., Fairris G.M., Rothwell J., Cunliffe W.J., Dixon M.F., and Axon A.T.R. Small intestinal permeability in dermatological disease. Quart. J. Med. 56 (1985) 559-567
91. Hamilton I., Hill A., Rose B., Boucher I.A.D., and Forsyth J.S. Small intestinal permeability in pediatric clinical practice. J. Pediat. Gastroenterol. Nutr. 6 (1987) 697-701
92. Hayllar J., Price A.B., Smith T., Macpherson A., Gumpel M.J., and Bjarnason I. Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss: effect of sulphasalazine and other disease modifying drugs. Arthritis Rheum. 37 (1994) 1146-1150
93. Hernandez G., Velasco N., Wainstein C., Castillo L., Bugedo G., Maiz A., Lopez F., Guzman S., and Vargas C. Gut mucosal atrophy after a short enteral fasting period in critically ill patients. J. Crit. Care 14 (1999) 73-77
94. Hill D.J., and Lynch B.C. Elemental diet in the management of severe eczema in childhood. Clin. Allergy 12 (1982) 313-315
95. Hilsden R.J., Meddings J.B., Hardin J., Gall D.G., and Sutherland L.R. Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse. Inflamm. Bowel. Dis. 5 (1999) 85-91
96. Hilsden R.J., Meddings J.B., and Sutherland L.R. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. Gastroenterology 110 (1996) 1395-1403
97. Hollander D., Rickets D., and Boyd C.A.R. Importance of 'probe' molecular geometry in determining intestinal permeability. Can. J. Gastroenterol. 2 A (1988) 35A-38A
98. Hollander D., Vadheim C., Brettholz E., Pattersen G.M., Delahunty T., and Rotter J.I. Increased intestinal permeability in patients with Crohn's disease and their relatives. Ann. Int. Med. 105 (1986) 883-885
99. Hong R., and Amman A.J. Selective absence of IgA: Autoimmune phenomena and autoimmune diseases. Human. Pathol. 69 (1972) 451-496
100. Howden C.W., Robertson C., Duncan A., Morris A.J., and Russell R.I. Comparison of different measurements of intestinal permeability in inflammatory bowel disease. Amer. J. Gastroenterol. 86 (1991) 1445-1449
101. Huber T., Ruchti C., and Halter F. Nonsteroidal antiinflammatory drug-induced colonic structures: a case report. Gastroenterology 100 (1992) 1119-1122
102. Iqbal T.H., Lewis K.O., and Cooper B.T. Diffusion of polyethylene glycol-400 across lipid barriers in vitro. Clin. Sci. 85 (1993) 111-115
103. Iqbal T.H., Lewis K.O., Gearty J.C., and Cooper B.T. Small intestinal permeability to mannitol and lactulose in the three ethnic groups resident in west Birmingham. Gut 39 (1996) 199-203
104. Iwata H., Matsushita M., Nishikimi N., Sakurai T., and Nimura Y. Intestinal permeability is increased in patients with intermittent claudication. J. Vasc. Surg. 31 (2000) 1003-1007
105. Jacob, M., 1999. Mechanism of nonsteroidal anti-inflammatory drug-induced damage in the small bowel. PhD Thesis, University of London.
106. Jalonen T. Identical intestinal permeability changes in children with different clinical manifestations of cow's milk allergy. J. Allergy Clin. Immunol. 88 (1991) 737-742
107. Jasin H.E. Bacterial lipopolysaccharides induce in vitro degradation of cartilate matrix through chondrocyte activation. J. Clin. Invest. 72 (1983) 2014-2019
108. Jenkins A.P., Menzies I.S., Nukajam W.S., and Creamer B. The effect of ingested lactulose on absorption of L-rhamnose, D-xylose and 3-0-methyl-D-glucose in subjects with ileostomies. Scand. J. Gastroenterol. 29 (1994) 820-825
109. Jenkins A.P., Menzies I.S., Nukajam W.S., Grellier L., Mathan V.I., and Creamer B. Geographical variation in intestinal permeability. Gut 30 (1989) A1509-A1510
110. Jenkins A.P., Nukajam W.S., Menzies I.S., and Creamer B. Simultaneous administration of lactulose and 51Cr-ethylenediaminetetraacetic acid. A test to distinguish colonic from small-intestinal permeability change. Scand. J. Gastroenterol. 27 (1992) 769-773
111. Jenkins A.P., Trew D.R., Nukajam W.S., Crump B.J., Menzies I.S., and Creamer B. Do nonsteroidal anti-inflammatory drugs increase colonic permeability?. Gut 32 (1991) 66-69
112. Johansen K., Stintzing G., Magnusson K.E., Sundquist T., Jalil F., Murtaza A., Khan S.R., Lindblad B.S., Mollby R., Orusild E., and Svensson L. Intestinal permeability assessed with polyethylene glycols in children with diarrhoea due to rotavirus and common bacterial pathogens in a developing country. J Pediat. Gastroenterol. Nutr. 9 (1989) 307-313
113. Jorgensen J., Runlov P.J., Bjerrum P.J., Diemer H., Bisgaard K., and Elsborg L. Is an increased intestinal permeability a valid predictor of relapse in Crohn's disease?. Scand. J. Gastroenterol. 36 (2001) 521-527
114. Juby L.D., Rothwell J., and Axon A.T.R. Cellobiose/mannitol sugar test: A sensitive tubeless test for coeliac disease. Results on 1010 unselected patients. Gut 30 (1989) 476-480
115. Juby L.D., Rothwell J., and Axon A.T.R. Lactulose/mannitol test. An ideal screening test for coeliac disease. Gastroenterology 96 (1989) 79 85
116. Juto P., Engberg S., and Winberg J. Treatment of infantile atopic dermatitis with a strict elimination diet. Clin. Allergy 8 (1978) 493-500
117. Katz K.D., Hollander D., Vadheim C.M., Mceleree C., Dalahunty T., Dadufalza V.D., Krugliak P., and Rotter J.I. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology 97 (1989) 927-931
118. Kawabata H., Meddings J.B., Uchida Y., Matsuda K., and Sasahara K. Sucrose permeability as a means of detecting disease of the upper gastrointestinal tract. Amer. J. Gastroenterol. 13 (1998) 1002-1006
119. Keating J., Bjarnason I., Somasundaram S., Macpherson A., Francis N., Price A.B., Sharpstone D., Smithson J., Menzies I.S., and Gazzard I.S. Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV infected patients and their relation to diarrhoea. Gut 37 (1995) 623-629
120. Keshavarzian A., Holmes E.W., Patel M., Iber F., Fields J.Z., and Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcoholic-induced liver damage. Amer. J. Gastroenterol. 94 (1999) 200-207
121. Kiziltas S., Imerynz N., Gurcon T., Siva A., Saip S., Dumankow A.L., Kalaya C., and Ulusoy N.B. Corticosteroid therapy augments gastroduodenal permeability to sucrose. Amer. J. Gastroenterol. 93 (1998) 2420-2425
122. Kohout P., Cerman J., Bratova M., and Zadak Z. Small bowel permeability in patients with cytostatic therapy. Nutrition 15 (1999) 546-549
123. Kokkonen J., Simila S., and Herva R. Gastrointestinal findings in atopic children. Eur. J. Pediat. 134 (1980) 249-252
124. Kompan L., Kremzar B., Gadzijev E., and Prosek M. Effects of early enteral nutrition on intestinal permeability and the development of multiple organ failure after multiple injury. Intens. Care Med. 25 (1999) 157-161
125. Krugilak P., Hollander D., Ma T.Y., Tran D., Dadufalza V.D., Katz K.D., and Ce K. Mechanism of polyethylene glycol 400 permeability of perfused rat intestine. Gastroenterology 97 (1989) 1164-1170
126. Laker M.F., Bull H.J., and Menzies I.S. Evaluation of mannitol for use as a probe marker of gastrointestinal permeability in man. Eur. J. Clin. Invest. 12 (1982) 485-491
127. Laker M.F., and Menzies I.S. Increase in human intestinal permeability following ingestion of hypertonic solutions. J. Physiol. (London) 265 (1977) 881-894
128. Laker M.F., and Mount J.N. Mannitol estimation in biological fluids by gas liquid chromatography of trimethylsilyl derivatives. Clin. Chem. 26 (1980) 441-443
129. Lang J., Price A.B., Levi A.J., Burk M., Gumpel J.M., and Bjarnason I. Diaphragm disease: the pathology of non-steroidal anti-inflammatory drug induced small intestinal structures. J. Clin. Path. 41 (1988) 516-526
130. Langkamp-Henken B., Donovan T.B., Pate L.M., Maull C.D., and Kudsk K.A. Increased intestinal permeability following blunt and penetrating trauma. Crit. Care Med. 23 (1995) 660-664
131. Langman M.J.S. Epidemiological evidence on the association between peptic ulceration and antiinflammatory drugs. Gastroenterology 96 (1989) 640-646
132. Langman M.J.S., Morgan L., and Worrall A. Use of anti-inflammatory drugs by patients with small or large bowel perforation and haemorrhage. Brit. Med. J. 290 (1985) 347 349
133. Langman M.J.S., Weil J., Wainwright P., Lawson D.H., Rawlins M.D., Logan R.F.A., Murphy M., Vessey M.P., and Colin-Jones D.G. Risk of bleeding peptic ulcers associated with individual non-steroidal anti-inflammatory drugs. Lancet 343 (1994) 1075-1078
134. Leclercq-Foucart J., Forget P., Sodoyez-Gouffaux F., and Zappitelli A. Intestinal permeability to 51CrEDTA in children with cystic fibrosis. J. Pediat. Gastroenterol. Nutr. 5 (1986) 384-387
135. Leclercq-Foucart J., Forget P., and Van Cutsem J.L. Lactulose-rhamnose intestinal permeability in children with cystic fibrosis. J. Pediat. Gastroenterol. Nutr. 6 (1987) 66-70
136. Leece J.G., and Morgan D.A. Effects of dietary regimen on cessation of intestinal absorption of large molecules (closure) in the neonatal pig and lamb. J. Nutr. 78 (1962) 263-268
137. Leirisalo-Repo H., and Repo H. Gut and spondyloarthropathies. Rheum. Clin N. Amer. 18 (1992) 23-35
138. Leirisalo-Repo H., Turunen U., Stenman S., Helenius P., and Seppala K. High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum. 37 (1994) 23-31
139. Lessof M.H., Wraith D.G., Merrett J., and Buisseret P.D. Food allergy and intolerance in 100 patients- Local and systemic effects. Quart. J. Med. 195 (1980) 259-271
140. Levi S., DeLacey G., Price A.B., Gumpel M.J., Levi A.J., and Bjarnason I. 'Diaphragm like' structures of the small bowel in patients treated with non-steroidal antiinflammatory drugs. Brit. J. Radiol. 63 (1990) 186-189
141. Lim S.G., Menzies I.S., Lee C.A., Johnson M.A., and Pounder R.E. Intestinal permeability and function in patients infected with human immunodeficiency virus. Scand. J. Gastroenterol. 28 (1993) 573-580
142. Lima A.A., Silva T.M., Gifoni A.M., Barrett L.J., McAuliffe I.T., Bao Y., Fox J.W., Fedorko D.P., and Guerrant R.L. Mucosal injury and disruption of intestinal barrier function in HIV-infected individuals with and without diarrhoea and cryptosporiasis in northeast Brazil. Amer. J. Gastroenterol. 92 (1997) 1861-1866
143. Liverani E., Silveri N.G., Gasbarrini G., and Mingrone G. Intestinal permeability increases with the severity of abdominal trauma: a comparison between gas liquid chromatographic and enzymatic method. Hepatogastroenterology 47 (2000) 1037-1041
144. Lobley R.W., Burrows P.C., Warwick R., Dawson D.J., and Holmes R. Simultaneous assessment of intestinal permeability and lactose tolerance with orally administered raffinose, lactose and L-arabinose. Clin. Sci. 79 (1990) 175-183
145. Lokken P. Norwegian Monographs in Medical Science. Studies on 51CrEDTA and its evaluation as a reference substance in gastrointestinal disease (1970), Universforlaget, Oslo
146. Ma T.Y., Hollander D., Krugliak P., and Katz K. PEG 400, a hydrophyllic molecular probe for measuring intestinal permeability. Gastroenterology 98 (1990) 39-46
147. Magnusson K.E., Sundquist T., Sjodahl R., and Tageson C. Altered intestinal permeability to low-molecular-weight polyethylene glycols (PEG 400) in patients with Crohn's disease. Acta Chir. Scand. 149 (1983) 323-327
148. Magnusson M., Magnusson K.E., Sundqvist T., and Denneberg T. Urinary excretion of differently sized polyethylene glycols after intravenous administration in uremic and control rats: effects of low- and high-protein diets. Nephron 56 (1990) 312-316
149. Magnusson M., Magnusson K.E., Sundqvist T., and Denneberg T. Reduced intestinal permeability measured by differently sized polyethylene glycols in acute uremic rats. Nephron 60 (1992) 193-198
150. Mahendra P., Bedlow A.J., Ager S., Ancliff P.J., Wraight E.P., and Marcus R.E. Technetium (99mTc)-labelled white cell scanning, 51Cr-EDTA and 14C-mannitol-labelled intestinal permeability studies: non-invasive methods of diagnosing acute intestinal graft-versus-host disease. Bone Marrow. Transplant. 13 (1994) 835-837
151. Mahmud T., Rafi S.S., Scott D.L., Wrigglesworth J.M., and Bjarnason I. Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation. Arthritis Rheum. 39 (1996) 1998-2003
152. Mahmud T., Scott D., and Bjarnason I. A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity. Ann. Rheum. Dis. 55 (1996) 211-213
153. Maxton D.G., Bjarnason I., Reynolds A.P., Catt S.D., Peters T.J., and Menzies I.S. Lactulose, 51CrEDTA, L-rhamnose and polyethylene glycol 400 as probe markers for in vivo assessment of human intestinal permeability. Clin. Sci. 71 (1986) 71-80
154. Maxton D.G., Catt S.D., and Menzies I.S. Intestinal disaccharidases assessed in congenital asucrasia by differential urinary disaccharide excretion. Dig. Dis. Sci. 34 (1989) 129-131
155. Maxton D.G., Catt S.D., and Menzies I.S. Combined assessment of intestinal disaccharidases in congenital asucrasia by differential urinary disaccharide excretion. J. Clin. Pathol. 43 (1990) 406-409
156. Maxton D.G., Menzies I.S., Slavin B., and Thompson R.P.H. Small intestinal function during enteral feeding and starvation in man. Clin. Sci. 77 (1989) 401-406
157. May G.R., Sutherland L.R., and Meddings J.B. Is small intestinal permeability really increased in relatives of patients with Crohn's disease?. Gastroenterology 104 (1993) 1627-1632
158. McCune K.H., Allen D., and Cranley B. Small bowel diaphragm disease-Strictures associated with non-steroidal anti-inflammatory drugs. Ulster Med. J. 61 (1992) 182-184
159. Meddings J.B., Sutherland L.R., Byles N.I., and Wallace J.L. Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology 104 (1993) 1619-1626
160. Menzies, I.S., 1984. Transmucosal passage of inert molecules in health and disease. In: Skad-hauge, E., Heintze, K. (Eds.), Intestinal absorption and secretion. Lancaster, Falk Symposium 36. MTP Press, 527-543.
161. Menzies I.S. Absorption of intact oligosaccharide in health and disease. Biochem. Soc. Transact. 2 (1974) 1042-1047
162. Menzies I.S., and Crane R.C. Quantitative estimation of sugars by thin-layer chromatography and scanning densitometry. Assessing intestinal absorptive capacity and permeability in vivo. In: Preedy V.R., and Watson R.R. (Eds). Methods in disease: Investigating the gastrointestinal tract (1998), Oxford University Press, Oxford 53-63
163. Menzies I.S., Jenkins A.P., Heduan E., Catt S.D., Segal M.B., and Creamer B. The effect of poorly absorbed solute on intestinal absorption. Scand. J. Gastroenterol. 25 (1990) 1257-1264
164. Menzies I.S., Pounder R., Heyer S., Laker M.F., Bull J., Wheeler P.G., and Creamer B. Abnormal intestinal permeability to sugars in villus atrophy. Lancet ii (1979) 1107-1109
165. Menzies I.S., Zuckerman M.J., Nukajam W.S., Somasundaram S., Murphy B., Jenkins A.P., Crane R.S., and Gregory G.G. Geography of intestinal permeability and absorption. Gut 44 (1999) 483-489
166. Morris A.D., Holt S.D., Silvoso G.R., Hewitt J., Tatum W., and Grandione J. The effect of anti-inflammatory drug administration in patients with rheumatoid arthritis. An endoscopic assessment. Scand. J. Gastroenterol. 16 67 (1991) 131-135
167. Morris A.J., Lee F.D., Capell H.A., McKenzie J.F., and Sturrock R.D. Jejunal lesins in ankylosing spondilitis are due to nonsteroidal anti-inflammatroy drug therapy. Arthritis Rheum. 9 (1996) S205
168. Morris A.J., Madhok R., Sturrock R.D., Capell H.A., and Mackenzie J.F. Entero-scopic diagnosis of small bowel ulceration in patients receiving non-steroidal antiinflammatory drugs. Lancet 337 (1991) 520
169. Morris A.J., Wasson L.A., and Mackenzie J.F. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 33 (1992) 887-889
170. Morris B., and Morris R. Macromolecular uptake and transport by the small intestine by the small intestine of suckling rat. In: Hemmings W.A. (Ed). Antigen absorption by the gut (1978), Lancaster MRP Press 23-30
171. Munkholm P., Langholz E., Hollander D., Thornberg K., Orholm M., Katz K.D., and Binder V. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Out 35 (1994) 68-72
172. Murphy B., Taylor C., Crane C., Kizza A., and Bjarnason I. A comparison between intestinal function in HIV seropositive patients in Kampala and London. Scand. J. Gastroenterol. 34 (1999) 491-495
173. Newton J.A., Maxton D.G., Bjarnason I., Reynolds A.P., and Menzies I.S. Intestinal permeability in atopic eczema. Clin. Sci. 67 (1984) 64P
174. Noone C., Menzies I.S., Banatvala J.E., and Scopes J.W. Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by noninvasive differential sugar permeation. Eur. J. Clin. Invest. 16 (1986) 217-225
175. Northrop-Clewes C.A., Lunn P.G., and Downes R.M. Lactose maldigestion in breastfeeding Gambian infants. J. Pediat. Gastroenterol. Nutr. 24 (1997) 257-263
176. O'Morain C., Abelon A.C., Chervli L.R., Fleischner G.M., and Das K.M. 51CrEDTA a useful test in the assessement of inflammatory bowel disease. J. Lab. Clin. Med. 108 (1986) 430-435
177. Obinna F.C., Cook G., Beale T., Dave S., Cunningham D., Fleming S.C., Claydon E., Harris J.W., and Kapembwa M.S. Comparative assessment of small intestinal and colonic permeability in HIV-infected homosexual men. AIDS 9 (1995) 1009-1016
178. Oman H., Akerblom E., Richter W., and Johansson S.G.O. Chemical and physiological properties of polysucrose, a new marker of intestinal permeability to macromolecules. Int. Arch. Allergy Immunol. 98 (1992) 220-226
179. Oman H., Blomquist L., Henriksson A.E.K., and Johansson S.G.O. Comparison of polysucrose 15000, 51Cr -labelled ethylenediaminotetraacetic acid, and 14C-mannitol as markers of intestinal permeability in man. Scand. J. Gastroenterol. 30 (1995) 1172-1177
180. Oman H., Henriksson A.E., Johansson S.G., and Blomquist L. Detection of naproxen-induced intestinal permeability change may be facilitated by adding a standardised meal but not by forming marker ratios. Scand. J. Gastroenterol. 31 (1996) 1182-1188
181. Paganelli R., Fagiolo U., Cancian M., Sturniolo G.C., Scala E., and D'Offizi G.P. Intestinal permeability in irritable bowel syndrome. Effect of diet and sodium chromogly-cate administration. Ann. Allergy 64 (1990) 377-380
182. Pape H.C., Dwenger A., Regel G., Auf'm'Kolck M., Gollub F., Wisner D., Sturm J.A., and Tscherne H. Increased gut permeability after multiple trauma. Brit. J. Surg. 81 (1994) 850-852
183. Parlesak A., Schafer C., Schutz T., Bode J.C., and Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J. Hepatol. 32 (2000) 742-747
184. Parrilli G., Iaffaioli R.V., Martorano M., Cuomo R., Tafuto S., Zampino M.G., Budillon G., and Bianco A.R. Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer. Cancer. Res. 49 (1989) 3689-3691
185. Pearson A.D.J., Craft A.W., Pledger J.V., Eastham E.J., Laker M.F., and Pearson C.S. Small bowel function in acute lymphoblastic leukemia. Arch. Dis. Child 59 (1984) 460-465
186. Peeters M., Geypens B., Claus D., Nevens H., Ghoos Y., Verbeke G., Baert F., Vermiere S., Vlietinck R., and Rutgeers P. Clustering of increased intestinal permeability in families with Crohn's disease. Gastroenterology 113 (1997) 802-807
187. Pernet P., Aussel C., Le Boucher J., Giboudeau J., Cynober L., and Coudray-Lucas C. Standardization of the lactulose-mannitol test in rats: application to burn injury. Eur. Surg. Res. 30 (1998) 69-74
188. Pernet P., Vittecoq D., Kodjo A., Randrianarisolo M.-H., Dumitrescu L., Blondon H., Bergmann J.-F., Giboudeau J., and Aussel C. Intestinal absorption and permeability in human immunodeficiency virus-infected patients. Scand. J. Gastroenterol. 34 (1999) 29-34
189. Picco P., Gattorno M., Marchese N., Vignola S., Sormani M.P., Barabino A., and Buoncompagni A. Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters. Clin. Exp. Rheumatol. 18 (2000) 773-778
190. Pike M.G., Heddle R.J., Boulton P., Turner M.W., and Atherton D.J. Increased intestinal permeability in atopic eczema. J. Invest. Dermatol. 86 (1986) 101-104
191. Pike M.G., Riches P., and Atherton D.J. Fecal a 1-Antitrypsin concentration and gastrointestinal permeability to oligosaccharides in atopic dermatitis. Pediat. Dermatol. 6 (1989) 10-12
192. Pledger J.V., Pearson A.D.J., Craft A.W., Laker M.F., and Eastham E.J. Intestinal permeability during chemotherapy for childhood tumors. Eur. J. Pediat. 147 (1988) 123-127
193. Qvist H., Somasundaram S., Macpherson A., Menzies I.S., Giercksky K., and Bjarnason I. The effect of pelvic radiation on small and large intestinal absorption and permeability in man. Gastroenterology 106 (1994) A430
194. Rabassa A.A., Goodgame R., Sutton F.M., Ou C.N., Rognerud C., and Graham D.Y. Effect of aspirin and Helicobacter pylori on the gastroduodenal mucosal permeability to sucrose. Gut 39 (1996) 159-163
195. Raj S.M., Sein K.T., Anuar A.K., and Mustaffa B.E. Effect of intestinal helminthiasis on intestinal permeability of early primary schoolchildren. Trans. R. Soc. Trop. Med. Hyg. 90 (1996) 666-669
196. Ramage J.K., Stanisz A., Scicchitano R., Hunt R.H., and Perdue M.H. Effects of immunologic reactions on rat intestinal epithelium. Correlation of increased intestinal permeability to chromium 51-labelled ethylenediaminetetraacetic acid and ovalbumin during acute inflammation and anaphylaxis. Gastroenterology 94 (1988) 1368-1375
197. Rask-Madsen J., and Schwartz M. Absorption of 51CrEDTA in ulcerative colitis following rectal instillation. Scand. J. Gastroenterol. 5 (1979) 361-368
198. Resnick R.H., Royal H., Marshall W., Barron R., and Werth T. Intestinal permeability in gastrointestinal disorders. Dig. Dis. Sci. 35 (1990) 205-211
199. Riordan S.M., McIver C.J., Thomas D.H., Duncombe V.M., Bolin T.D., and Thomas M.C. Luminal bacteria and small-intestinal permeability. Scand. J. Gastroenterol. 32 (1997) 556-563
200. Roberton D.M., Paganelli R., Dinwiddil R., and Levinsky R.J. Milk antigen in the preterm and term neonate. Arch. Dis. Child 57 (1982) 369-372
201. Rodrigues L.A.G., and Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 343 (1994) 769-772
202. Romiti A., Merli M., Martorano M., Parilli G., Martino F., Riggio O., Trucelli A., Copocaccia L., and Budillion G. Malabsorption and nutritional abnormalities in patients with liver cirrhosis. Ital. J. Gastroenterol. 22 (1990) 118-123
203. Ryan A.J., Chang R.T., and Gisolfi C.V. Gastrointestinal permeability following aspirin intake and prolonged running. Med. Sci. Sports Exerc. 28 (1996) 698-705
204. Saltzman J.R., Kowdley K.V., Perrone G., and Russell R.M. Changes in small-intestine permeability with aging. J. Amer. Geriatr. Soc. 43 (1995) 160-164
205. Sanderson I.R., Boulton P., Menzies I.S., and Walker-Smith J.A. Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet. Gut 28 (1987) 1073-1076
206. Santini R., Perez-Santiago E., Martinez-De-Jesus J., and Butterworth C.E. Evidence of increased intestinal absorption of molecular sucrose in sprue. Amer. J. Dig. Dis. 2 (1957) 663-668
207. Scadding C., Bjarnason I., Brostoff J., Levi A.J., and Peters T.J. Intestinal permeability to 51Cr-labelled ethylenediaminetetraacetate in food-intolerant subjects. Digestion 42 (1989) 104-109
208. Scarpignatio C., Bjarnason I., Bretagne J.-F., de Pouvourville G., Garcia Rodriguez L.A., Goldstein J.L., Muller P., and Simon B. Towards a GI safer antiinflammatory therapy. Gastroenterol. Int. 12 (1999) 180-215
209. Schrander J.J.P., Unsalan-Hooyen R.W.M., Forest P.P., and Jansen J. [51Cr]EDTA intestinal permeability in children with cow's milk intolerance. J. Pediat. Gastroenterol. Nutr. 10 (1990) 189-192
210. Selby P.J., Lopes N., Mundy J., Crofts M., Millar J.L., and McElwain T.J. Cyclophosphomide priming reduces intestinal damage in man following high dose melphalan chemotherapy. Brit. J. Cancer. 55 (1987) 531-533
211. Serrander R., Magnusson K.E., Kihlstrom E., and Sundquist T. Acute Yersinia infection in man increases intestinal permeability for low-molecular weight polyethylene glycols (PEG 400). Scand. J. Infect. Dis. 18 (1989) 409-413
212. Serrander R., Magnusson K.E., and Sundquist T. Acute infection with giardia lamblia and rotavirus decrease intestinal permeability to low molecular weight polyethylene glycols (PEG 400). Scand. J. Infect. Dis. 16 (1984) 339-344
213. Shah A.A., Thjodleifsson B., Murray F.E., Sigthorsson G., Oddson E., Gudjonsson H., Price A.B., Fitzgerald D.J., and Bjarnason I. Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen. Gut 48 (2001) 339-346
214. Shulman R.J., Schanler R.J., Lau C., Heitkemper M., Ou C.N., and Smith E.O. Early feeding, antenatal glucocorticoids, and human milk decrease intestinal permeability in preterm infants. Pediat. Res. 44 (1998) 19-23
215. Sigthorsson G., Crane R., Simon T., Hoover M., Quan H., Bolognese J., and Bjarnason I. COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin. Gut 47 (2000) 527-532
216. Sigthorsson G., Jacob M., Wrigglesworth J.M., Somasundaram S., Tavares I., Foster R., Roseth A., Rafi S., Mahmud T., Simpson R., and Bjarnason I. A comparison of indomethacin and nimesulide, a selective cyclooxygenase-2 inhibitor, on key pathophysiological steps in the pathogenesis of nsaid enteropathy in the rat. Scand. J. Gastroenterol. 33 (1998) 728-735
217. Sigthorsson G., Tibble J., Hayllar J., Menzies I., Macpherson A., Moots R., Scott D.G.M.J., and Bjarnason I. Intestinal permeability and inflammation in patients on NSAIDs. Gut 43 (1998) 506-511
218. Smale S., Natt R.S., Orchard T.R., Russell A.S., and Bjarnason I. Inflammatory disease and spondylarthropathy. Arthritis Rheum (2001) (in press)
219. Smecuol E., Bai J.C., Vazques H., Kogan Z., Cabanne A., Niveloni S., Pedreira S., Boerr L., Maurino E., and Meddings J.B. Gastrointestinal permeability in coeliac disease. Gastroenterology 112 (1997) 1129-1136
220. Smethurst P., Menzies I.S., Levi A.J., and Bjarnason I. Is alcohol directly toxic to the small bowel mucosa?. Clin. Sci. 75 (1988) 50-51P
221. Smetonika R.D., Lambert O.P., Murray R., Eddy D., Horn M., and Giosolfi C.V. Intestinal permeability in runners in the 1996 Chicago marathon. Int. J. Sport. Nutr. 9 (1999) 426 433
222. Soderholm J.D., Olaison G., Lindberg E., Hannestad U., Vindels A., Tysk C., Janerot G., and Sjodahl R.I. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence?. Gut 44 (1999) 96-100
223. Soderholm J.D., Oman H., Blomquist L., Veen J., Lindmark T., and Olaison G. Reversible increase in tight junction permeability to macromolecules in rat ileal mucosa in vitro by sodium caprate, a constituent of milk fat. Dig. Dis. Sci. 43 (1998) 1547-1552
224. Somasundaram S., Hayllar J., Rati S., Wrigglesworth J., Macpherson A., and Bjarnason I. The biochemical basis of NSAID-induced damage to the gastrointestinal tract: A review and a hypothesis. Scand. J. Gastroenterol. 30 (1995) 289-299
225. Somasundaram S., Rafi S., Hayllar J., Sigthorsson G., Jacob M., Price A.B., Macpherson A., Mahmod T., Scott D., Wrigglesworth J.M., and Bjarnason I. Mitochondrial damage: A possible mechanism of the topical phase of NSAID-induced injury to the rat intestine. Gut 41 (1997) 344-353
226. Somasundaram S., Sigthorsson G., Price A.B., Tavares I.A., Rafi S., Mahmud T., Roseth A., Foster R., Macpherson S., Wrigglesworth J.M., and Bjarnason I. The relative importance of inhibition of cyclooxygenase and uncoupling of oxidative phosphorylation in the gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. Alim. Pharm. Therap. 14 (2000) 639-650
227. Stenhammar L., Falth-Magnusson K., Jansson G., Magnusson K.E., and Sundqvist T. Intestinal permeability to inert sugars and different-sized polyethyleneglycols in children with celiac disease. J. Pediat. Gastroenterol. Nutr. 9 (1989) 281-289
228. Stintzing G., Johansen K., Magnusson K.E., Svensson L., and Sundquist T. Intestinal permeability in small children during and after rotavirus diarrhoea assessed with different-sized polyethylene glycols (PEG 400 and PEG 1000). Acta Pediat. Scand. 75 (1986) 1005-1009
229. Stott G.H., Marx D.B., Menefee B.E., and Nightengale G.T. Colostra immunoglobulin transfer in calves. I. Period of absorption. J. Diary Sci. 62 (1979) 1632-1638
230. Sullivan P.B., Lunn P.G., Northrop C.C., Crowe P.T., Marsh M.N., and Neale G. Persistent diarrhea and malnutrition-the impact of treatment on small bowel structure and permeability. J. Pediat. Gastroenterol. Nutr. 14 (1992) 208-215
231. Sundquist T., Magnusson K.E., Larsson L., Tageson C., Backman L., and Nordenvall B. Reduced intestinal permeability to low-molecular-weight polyethylene glycols (PEG400) in patients with jejunoileal bypass. Acta Chir Scand 150 (1984) 567-571
232. Sundquist T., Magnusson K.E., Sjodahl R., Stjernstrom I., and Tageson C. Passage of molecules through the wall of the gastrointestinal tract. II. Application of low-molecular weight polyethyleneglycol and a deterministic mathematical model for determining intestinal permeability in man. Gut 21 (1980) 208-214
233. Sundqvist T., Tageson C., and Magnusson K.E. Simulation of a multicompartment model for the intestinal permeability to low-molecular-weight probes (polyethylene glycol 400). Mathemat. Biosci. 56 (1981) 287-309
234. Sutherland L.R., Verhoef M., Wallace J.L., Rosendaahl G.V., Crutcher R., and Meddings J.B. A simple, non-invasive marker of gastric damage: sucrose permeability. Lancet 343 (1994) 998-1000
235. Taylor C., Hodgson K., Sharpstone D., Sigthorsson G., Coutts M.I., Sherwood R., Menzies I.S., Gazzard B., and Bjarnason I. The prevalence and severity of intestinal disaccharidase deficiency in HIV-infected subjects. Scand. J. Gastroenterol. 35 (2000) 599-606
236. Teahon K., Smethurst P., Levi A.J., and Bjarnason I. The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease. Gastroenterology 101 (1991) 84-89
237. Teahon K., Smethurst P., Levi A.J., Menzies I.S., and Bjarnason I. Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 33 (1992) 320-323
238. Teahon K., Smethurst P., Macpherson A.J., Levi A.J., Menzies I.S., and Bjarnason I. Intestinal permeability in Crohn's disease and its relation to disease activity and relapse following treatment with elemental diet. Eur. J. Gastroenterol. Hepatol. 5 (1993) 79-84
239. Teahon K., Somasundaram S., Smith T., Menzies I., and Bjamason I. Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease. Gut 38 (1996) 864-869
240. Teahon K., Webster A.D., Price A.B., and Bjarnason I. Studies of gastrointestinal structure and function in patients with primary hypogammaglobulinaemia. Gut 35 (1994) 1244-1249
241. Teichberg S., Isolauri E., Wapnir R.A., Roberts B., and Lifshitz F. Development of the neonatal rat small intestinal barrier to nonspecific macromolecular absorption: effect of early weaning to artificial diets. Pediat. Res. 28 (1990) 31-37
242. Tepper R.E., Simon. D., Brandt L.J., Nutovits R., and Lee M.J. Intestinal permeability in patients with the human immunodeficiency virus. Amer. J. Gastroenterol. 89 (1994) 878-882
243. Tibbie J., Sigthorsson G., Fagerhol M., and Bjarnason I. Surrogate markers of intestinal inflammation are predictive for relapse in patients with inflammatory bowel disease. Gastroenterology 119 (2000) 15-22
244. Tibbie J., Sigthorsson G., Foster R., Scott D., Roseth A., and Bjarnason I. Faecal cal-protectin: A simple method for the diagnosis of NSAID-induced enteropathy. Gut 45 (1999) 362-366
245. Travis S., and Menzies I.S. Intestinal permeability: functional assessment and significance. Clin. Sci. 82 (1992) 471-488
246. Uil J.J., van Elburg R.M., Janssens P.M., Mulder C.J., and Heymans H.S. Sensitivity of hyperosmolar or low -osmolar test solution for sugar absorption in recognising small intestinal mucosal damage in coeliac disease. Dig. Liver. Dis. 32 (2001) 195-200
247. Ukabam S.O., Clamp J.R., and Cooper B.T. Abnormal intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon. Digestion 27 (1982) 70-74
248. Ukabam S.O., Homeda M.A., and Cooper B.J. Small intestinal permeability in Sudanese subjects: Evidence of tropical enteropathy. Trans. Roy. Soc. Trop. Med. Hyg. 40 (1986) 204-207
249. Ukabam S.O., Mann R.J., and Cooper B.T. Small intestinal permeability to sugars in patients with atopic eczema. Brit. J. Dermatol. 110 (1984) 649-652
250. van der Hulst R.R., von Meyenfeldt M.F., van Kreel B.K., Thunnissen F.B., Brummer R.J., Arends J.W., and Soeters P.B. Gut permeability, intestinal morphology, and nutritional depletion. Nutrition 14 (1998) 1-6
251. Van Der Meer S.B., Forget P.P., and Heidendal G.A. Small bowel permeability to 51Cr-EDTA in children with recurrent abdominal pain. Acta Paediat. Scand. 79 (1990) 422-426
252. van Elburg R.M., Uil J.J., van Aalderen W.M., Mulder C.J., and Heymans H.S. Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis. Pediat. Res. 39 (1996) 985-991
253. Vogelsang H., Oberhuber G., and Wyatt J. Lymphocytic gastritis and gastric permeability in patients with coeliac disease. Gastroenterology 111 (1996) 73-77
254. Vukavic T. Timing of the gut closure. J. Pediatr. Gastroenterol. Nutr. 3 (1984) 700-703
255. Wallace J.L. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 112 (1997) 1000-1016
256. Wallace J.L., and Granger D.N. Pathogenesis of NSAID gastropathy: are neutrophils the culprits?. Trends Pharmacol. Sci. 13 (1992) 129-130
257. Walsh D.S., Thavichaigarn P., Dheeradhada C., Jiarakul N., Pearce F.C., Wiesmann W.P., Cioffi W.G., and Webster U.K. Prolonged alteration in gut permeability following nonthermal injury. Injury 27 (1996) 491-494
258. Weaver L.T. The impact of milk and weaning diet on gastrointestinal permeability in English and Gambian infants. Transact of the Royal Soc. Trop. Med. Hyg. 82 (1988) 784-789
259. Weaver L.T., Laker M.F., and Nelson R. Intestinal permeability in the newborn. Arch. Dis. Child 59 (1984) 236-241
260. Welsh F.K., Ramsden C.W., MacLennan K., Sheridan M.B., Barclay G.R., Guillou P.J., and Reynolds J.V. Increased intestinal permeability and altered mucosal immunity in cholestatic jaundice. Ann. Surg. 227 (1998) 205-212
261. Wheeler P.G., Menzies I.S., and Creamer B. Effect of hyperosmolar stimuli and coeliac disease on the permeability of the human gastrointestinal tract. Clin. Sci. Mol. Med. 54 (1978) 495-501
262. Whittle B.J.R. Unwanted effects of aspirin and related agents on the gastrointestinal tract. In: Vane J.R., and Botting R.M. (Eds). Aspirin and other salicylates (1992), Chapman & Hall Medical, London 465-509
263. Wicks C., Somasundaram S., Menzies I.S., Bjarnason I., and Williams R. Intestinal function and postoperative enteral nutrition following liver transplants. Gut 34 1 (1993) S65
264. Wilairatana P., Meddings J.B., Ho M., Vannaphan S., and Looareesuwan S. Increased gastrointestinal permeability in patients with Plasmodium falciparum malaria. Clin. Inf. Dis. 24 (1997) 430-435
265. Willumsen J.F., Darling J.C., Kitundu J.A., Kingamkono R.R., Msengi A.E., Mduma B., Sullivan K.R., and Tomkins A.M. Dietary management of acute diarrhoea in children: effect of fermented and amylase-digested weaning foods on intestinal permeability. J. Pediat. Gastroenterol. Nutr. 24 (1997) 235-241
266. Wyatt J., Vogelsang H., Hubl W., Waldhoer T., and Lochs H. Intestinal permeability and the predictor of relapse in Crohn's disease. Lancet 341 (1993) 1437-1439
267. Yacyshyn B., Meddings J., Sadowski D., and Bowen-Yacyshyn M.B. Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability. Dig. Dis. Sci. 41 (1996) 2493-2498
268. Yacyshyn B.R., and Meddings J.B. CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability. Gastroenterology 108 (1995) 132-137
269. Zhang Y., Lee B., Thompson M., Glass R., Lee R.C., Figueroa D., Gilman R., Taylor D., and Stephenson C. Lactulose-mannitol intestinal permeability test in children with diarrhea caused by rotavirus and Cryptosporidium. Diarrhea Working Group, Peru. J. Pediat. Gastroenterol. Nutr. 31 (2000) 16-21